Ronald M Witteles

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
    J Card Fail 18:804-9. 2012
  2. doi request reprint Use and overuse of left ventriculography
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305 5406, USA
    Am Heart J 163:617-23.e1. 2012
  3. ncbi request reprint Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    J Am Coll Cardiol 50:1835-40. 2007
  4. doi request reprint Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    J Am Coll Cardiol 51:93-102. 2008
  5. doi request reprint Chemotherapy-associated cardiotoxicity: how often does it really occur and how can it be prevented?
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Falk CVRC, Stanford, CA 94305, USA
    Heart Fail Clin 7:333-44. 2011
  6. ncbi request reprint Cardiomyopathy of insulin resistance
    Ronald M Witteles
    Stanford University School of Medicine, Stanford, CA 94305 5406, USA
    Heart Fail Clin 2:13-23. 2006
  7. doi request reprint Cardiac testing to manage cardiovascular risk in cancer patients
    Margot Davis
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305 5406, USA
    Semin Oncol 40:147-55. 2013
  8. doi request reprint Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?
    Geoffrey J Yoon
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
    J Am Coll Cardiol 56:1644-50. 2010
  9. doi request reprint Measurement precision in the optimization of cardiac resynchronization therapy
    Robert G Turcott
    Division of Cardiovascular Medicine and Center for Biomedical Informatics Research, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
    Circ Heart Fail 3:395-404. 2010
  10. doi request reprint Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies
    Brandon C Varr
    Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA, USA
    J Heart Lung Transplant 31:325-31. 2012

Collaborators

Detail Information

Publications12

  1. doi request reprint Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
    J Card Fail 18:804-9. 2012
    ..The purpose of this mechanistic study was to evaluate the effects of treatment with the dipeptidyl peptidase (DPP) 4 inhibitor sitagliptin on myocardial glucose uptake in patients with nonischemic cardiomyopathy...
  2. doi request reprint Use and overuse of left ventriculography
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305 5406, USA
    Am Heart J 163:617-23.e1. 2012
    ..We sought to analyze the frequency that left ventriculography was performed during coronary angiography in patients with and without a recent alternative assessment of left ventricular function...
  3. ncbi request reprint Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    J Am Coll Cardiol 50:1835-40. 2007
    ..Our purpose was to evaluate the impact of nesiritide on renal function in patients with acute decompensated heart failure and baseline renal dysfunction...
  4. doi request reprint Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    J Am Coll Cardiol 51:93-102. 2008
    ..This article reviews the basic science evidence, animal experiments, and human clinical data supporting the existence of an "insulin-resistant cardiomyopathy" and proposes specific potential therapeutic approaches...
  5. doi request reprint Chemotherapy-associated cardiotoxicity: how often does it really occur and how can it be prevented?
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Falk CVRC, Stanford, CA 94305, USA
    Heart Fail Clin 7:333-44. 2011
    ....
  6. ncbi request reprint Cardiomyopathy of insulin resistance
    Ronald M Witteles
    Stanford University School of Medicine, Stanford, CA 94305 5406, USA
    Heart Fail Clin 2:13-23. 2006
  7. doi request reprint Cardiac testing to manage cardiovascular risk in cancer patients
    Margot Davis
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305 5406, USA
    Semin Oncol 40:147-55. 2013
    ....
  8. doi request reprint Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?
    Geoffrey J Yoon
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
    J Am Coll Cardiol 56:1644-50. 2010
    ....
  9. doi request reprint Measurement precision in the optimization of cardiac resynchronization therapy
    Robert G Turcott
    Division of Cardiovascular Medicine and Center for Biomedical Informatics Research, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
    Circ Heart Fail 3:395-404. 2010
    ..A variety of techniques are used to estimate optimum AV/VV intervals; however, the precision of their estimates and the ramifications of an imprecise estimate have not been characterized previously...
  10. doi request reprint Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies
    Brandon C Varr
    Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA, USA
    J Heart Lung Transplant 31:325-31. 2012
    ..A novel strategy of OHT, followed by light-chain suppressive chemotherapy before autologous hematopoietic stem cell transplant, is feasible for patients with light-chain amyloidosis...
  11. ncbi request reprint Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link
    Ronald M Witteles
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California 94305 5406, USA
    J Am Coll Cardiol 44:78-81. 2004
    ..This study was designed to quantify the prevalence of abnormal glucose tolerance and insulin resistance in patients with idiopathic dilated cardiomyopathy (IDCM)...
  12. ncbi request reprint Trastuzumab-related cardiac dysfunction
    Melinda L Telli
    Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA 94305 5826, USA
    J Natl Compr Canc Netw 9:243-9. 2011
    ....